VolitionRx Limited (VNRX) Free cash flow 2016–2025
VolitionRx Limited (VNRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$19.8MFY2025 · since FY2016: -$9.3M → -$19.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.8M | +24.4% |
| FY2024 | -$26.2M | -36.7% |
| FY2023 | -$19.1M | -13.6% |
| FY2022 | -$16.8M | +22.8% |
| FY2021 | -$21.8M | -18.6% |
| FY2020 | -$18.4M | -38.9% |
| FY2019 | -$13.3M | +11.9% |
| FY2018 | -$15.0M | -10.4% |
| FY2017 | -$13.6M | -46.8% |
| FY2016 | -$9.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VNRX financial trends
VNRX RevenueVNRX Net incomeVNRX Net marginVNRX Gross profitVNRX Gross marginVNRX Operating incomeVNRX Operating marginVNRX Operating cash flowVNRX Capital expendituresVNRX Return on equityVNRX Stock buybacksVNRX Dividends paidVNRX Total assetsVNRX Total liabilitiesVNRX Shareholders’ equityVNRX overview →